NKTR-181 ( NKTR 181 | NKTR181 | Loxicodegol )

产品货号. M10788 CAS No. 1211231-76-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

NKTR-181
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

一种新型、长效、口服活性、选择性 mu-阿片类激动剂。
产品描述

A novel, long-acting and orally active, selective mu-opioid agonist that displays higher binding affinity (Ki=237 nM) at the MOR than kappa and delta opioid receptors (>100-fold); demonstrates maximum analgesic activity comparable to that of oxycodone in hot-plate latency and acetic-acid writhing models, reduces its rate of entry across the blood-brain barrier compared with traditional mu-opioid agonists.Pain Phase 3 Clinical.
体外实验

——
体内实验

——
同义词

NKTR 181 | NKTR181 | Loxicodegol
通路

Endocrinology/Hormones
靶点

Opioid Receptor
受体

Opioid Receptor
研究领域

Neurological Disease
适应症

Pain

CAS Number

1211231-76-3
分子量

595.73
分子式

C31H49NO10
纯度

>98% (HPLC)
溶解度

——
SMILES

O[C@]1([C@H](N(C)CC2)C3)[C@@]42C5=C3C=CC(OC)=C5O[C@H]4[C@@H](OCCOCCOCCOCCOCCOCCOC)CC1
化学全称

(4R,4aS,7S,7aR,12bS)-7-((2,5,8,11,14,17-hexaoxanonadecan-19-yl)oxy)-9-methoxy-3-methyl-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinolin-4a-ol

1. Miyazaki T, et al. J Pharmacol Exp Ther. 2017 Oct;363(1):104-113. 2. Webster L, et al. Pain Med. 2017 Mar 10. doi: 10.1093/pm/pnw344.

计算器

产品手册

关联产品

Cebranopadol

Cebranopadol (GRT-6005, GRT6005) 是一种有效的镇痛药，伤害感受肽/孤啡肽 FQ 肽 (NOP) 和阿片受体激动剂，Ki/EC50 为 0.9/13 nM（人 NOP 受体）、0.7/1.2 nM（mu-阿片受体）。
UFP-101

Potent, selective and competitive silent antagonist for the NOP opioid receptor. Binds to NOP with high affinity (pKi = 10.24) and displays > 3000-fold selectivity over δ, μ and κ opioid receptors. Antinociceptive and opposes the action of nociceptin in vivo.
Meptazinol hydrochlo...

Meptazinol Hcl(WY-22811 Hcl) 是一种独特的中枢活性阿片类镇痛化合物。